Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy

What is it about?

In a high-severity scenario such as cardiogenic shock after ST-segment elevation myocardial infarction, risk stratification offers important prognostic information and may direct the selection of patients for advanced therapies. Our findings reveal that, particularly in a population treated with pharmacoinvasive strategy, the IABP-SHOCK II score is suitable. Pain-to-needle and fibrinolytic-catheterization times didn’t interfere with the ability to the model stratification. The results incorporate a prognostic and epidemiological knowledge about cardiogenic shock.

Featured Image